TGFB1 and hypertensive disorder: Our work suggests that reno-protective strategies could potentially lower circulating TMAO and therefore preserve kidney function in individuals with high circulating TMAO in the presence of risk factors known to increase TGF-β1 signaling (i.e., hypertension and T2D58).